News

Dow Jones Expands Portfolio with Acquisition of Key Firms

Dow Jones Expands Portfolio with Acquisition of Key Firms

Dow Jones Acquires Dragonfly Intelligence and Oxford Analytica

In a strategic move aimed at strengthening its capabilities in geopolitical analysis, Dow Jones has announced the acquisition of Dragonfly Intelligence and Oxford Analytica for a total of $40 million from the entity known as FiscalNote Holdings, Inc. This acquisition is expected to finalize in early 2025, pending regulatory approvals.

Enhancing Geopolitical Intelligence Services

The addition of these firms to Dow Jones's existing portfolio is a significant step forward. Both Dragonfly and Oxford Analytica will be integrated into the Dow Jones Risk & Compliance division. This integration aims to enhance the offerings of geopolitical risk and security intelligence services, which have become increasingly crucial for businesses navigating today's complex environment filled with rising tensions.

The Role of Dragonfly Intelligence

Dragonfly Intelligence, providing vital geopolitical and security intelligence, positions itself as a trusted partner for crisis management and risk assessments. This firm assists organizations—ranging from multinational corporations to public sectors—in identifying and addressing security challenges. They deliver real-time data, early warnings of potential risks, and individual access to expert analysts that help clients respond proactively to emergent threats.

Oxford Analytica's Expertise

Founded in 1975, Oxford Analytica stands out as a prominent provider of macroeconomic risk analysis. Leveraging a rich network of global experts, the firm equips organizations with critical insights to navigate the complexities of an ever-evolving market landscape. Their work helps clients make informed decisions regarding policies, strategies, and investments critical to their success.

The Growing Demand for Risk Assessment

Almar Latour, CEO of Dow Jones, emphasized that businesses are increasingly reliant on credible analyses and trustworthy data to make strategic decisions. The current global landscape is marked by rapid changes in technology, geopolitics, and economic conditions, prompting businesses to seek analysis that can aid in navigating these complexities. The integration of Dragonfly and Oxford Analytica is a response to this growing need.

Continued Expansion for Dow Jones

This acquisition is part of a broader trend of growth for Dow Jones Risk & Compliance, which reported a remarkable 16% increase in revenue year-on-year, reaching approximately $300 million. Recent investments also include the acquisition of WorldECR, a news and analysis provider specializing in global trade compliance, and an increased stake in Ripjar, further highlighting Dow Jones's commitment to expanding its data-driven services.

Commitment to Risk and Compliance

The consistent growth of Dow Jones Risk & Compliance underscores its importance within the company. It highlights Dow Jones's commitment to becoming a leading source of information for the risk and compliance community, essential in today's business environment.

About Dow Jones

Dow Jones has established itself as a reputable global provider of news and business information for over 130 years. Its portfolio includes prominent publications like The Wall Street Journal, Barron's, MarketWatch, and many more, serving a diverse clientele across various platforms.

About FiscalNote

FiscalNote (NYSE: NOTE) is recognized as a premier provider of policy and regulatory intelligence solutions. By integrating AI technology with extensive data analysis, FiscalNote aids organizations in managing political and business risks efficiently.

Frequently Asked Questions

What is the recent acquisition by Dow Jones?

Dow Jones has acquired Dragonfly Intelligence and Oxford Analytica from FiscalNote for $40 million to enhance its geopolitical analysis capabilities.

When is the acquisition expected to finalize?

The acquisition is expected to close in the first quarter of 2025, subject to regulatory approvals.

What services do Dragonfly Intelligence and Oxford Analytica provide?

Dragonfly specializes in geopolitical and security intelligence, while Oxford Analytica focuses on macroeconomic risk analysis, both aiding businesses in navigating complex market situations.

How has Dow Jones's revenue been impacted by recent acquisitions?

Dow Jones Risk & Compliance reported a 16% year-over-year revenue growth, reaching nearly $300 million, driven by its expanding data products and services.

What is Dow Jones's mission?

Dow Jones aims to deliver high-quality news and intelligence to help businesses and professionals make informed decisions in a rapidly changing global landscape.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Real-Time Video Solutions with Haivision on AWS

Updated Category News Views 90

Haivision StreamHub and MoJoPro Revolutionize Mobile Broadcasting Haivision Systems Inc. (TSX: HAI), a leader in real-time video networking, has launched an innovative mobile broadcasting solution. Now available on the AWS Marketplace, the pairing of Haivision StreamHub with the MoJoPro app changes the game for journalists, video professionals, and broadcasters. They can...

Continue Reading
Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's

Updated Category News Views 298

Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's In a noteworthy announcement, Keurig Dr Pepper Inc. (NASDAQ: KDP) and JDE Peet's N.V. are making headlines with their plans regarding a public offer. This joint statement serves to inform stakeholders about the progress on KDP's intended recommended public offer for all outstanding shares of JDE Peet's. Basis...

Continue Reading
Join Wreaths Across America: Make a Difference This Season

Updated Category News Views 93

Join Wreaths Across America This December This December, Wreaths Across America (WAA), a national nonprofit, is gearing up for a meaningful wreath season. With over 20 new loads in need of carrier support, WAA is on the lookout for dedicated carriers and professional drivers who want to take part in its mission to Remember, Honor, and Teach. This initiative is set to...

Continue Reading
iMD Companies to Introduce New Product Line for Supplements

Updated Category News Views 159

iMD Companies and Riize Health Launch New Supplements iMD Companies, Inc. (OTC: ICBU) and its subsidiary, Riize LLC, are making waves in the health sector by introducing three new non-prescription products designed for online and retail distribution. The launch is set for the first quarter of the upcoming year and aims to cater directly to consumer needs in the...

Continue Reading
Activist Investors Surge: A Look into 2025's Landscape

Updated Category News Views 1737

Activist Investors Surge in 2024 By Svea Herbst-Bayliss A remarkable shift occurred in 2024 as a record number of activist shareholders launched campaigns aimed at global companies. Recent reports highlight that tactics employed by these shareholders have yielded impressive returns, which suggests a continued rise in these activities as we progress into the future. Rising...

Continue Reading